Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously hypertensive rats: Effects of antioxidant (Honey) treatment

International Journal of Molecular Sciences

Volumn 12, Issue 3, 2011, Pages 1888-1907

  Erejuwa, Omotayo O ^a   Sulaiman, Siti A ^a   Wahab, Mohd Suhaimi Ab ^a   Sirajudeen, Kuttulebbai N S ^a   Salleh, Md Salzihan Md ^a   Gurtu, Sunil ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Antioxidant enzymes; Diabetes mellitus; Hypertension; Kidney; Oxidative stress; Spontaneously hypertensive rats; Streptozotocin; Tualang honey

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; NATURAL PRODUCT; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; GLUTATHIONE; OXIDOREDUCTASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HONEY; HYPERTENSION; KIDNEY; MORNING DOSAGE; NONHUMAN; OXIDATIVE STRESS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE; TUALANG HONEY; WISTAR KYOTO RAT; ANALYSIS; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; TOXICITY;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HONEY; HYPERTENSION; KIDNEY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STREPTOZOCIN;

EID: 79953318436     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12031888     Document Type: Article

References (58)

1. Kannel, W.B.; McGee, D.L. Diabetes and cardiovascular disease: The Framingham study. JAMA 1978, 241, 2035-2038.
2. Christlieb, A.R. Diabetes and hypertensive vascular disease. Am. J. Cardiol. 1973, 32, 592-606.
3. Fein, F.S.; Capasso, J.M.; Aronson, R.S.; Cho, S.; Nordin, C.; Miller-Green, B.; Sonnenblick, E.H.; Factor, S.M. Combined renovascular hypertension and diabetes in rats: A new preparation of congestive cardiomyopathy. Circulation 1984, 70, 318-330.
4. Ross, R. The pathogenesis of atherosclerosis. N. Engl. J. Med. 1986, 314, 488-500.
5. Reaven, G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 1995, 75, 473-486.
6. Pieper, G.M.; Gross, G.J. Oxygen-derived free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 1988, 255, H825-H833.
7. Tesfamariam, B.; Cohen, R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 1992, 263, H321-H326.
8. Ohara, Y.; Petersen, T.E.; Harrison, D.G. Hypercholesterolemia increases endothelial O2- anion production. J. Clin. Invest. 1993, 91, 2546-2551.
9. Marui, N.; Offerman, M.K.; Swerlick, R.; Kunsch, C.; Rosen, C.A.; Ahmad, M.; Alexander, R.W.; Medford, R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 1993, 92, 1866-1874.
10. Laight, D.W.; Desai, K.M.; Anggard, E.E.; Carrier, M.J. Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur. J. Pharmacol. 2000, 402, 95-99.
11. Weber, C.; Erl, W.; Pietsch, A.; Strobel, M.; Ziegler-Heitbrock, H.W.L.; Weber, P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 1994, 14, 1665-1673.
12. Friedman, J.; Peleg, E.; Kagan, T.; Shnizer, S.; Rosenthal, T. Oxidative stress in hypertensive, diabetic, and diabetic hypertensive rats. Am. J. Hypertens. 2003, 16, 1049-1052.
13. Tan, H.T.; Rahman, R.A.; Gan, S.H.; Halim, A.S.; Hassan, S.A.; Sulaiman, S.A.; Kirnpal-Kaur, B. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey. BMC Complement. Altern. Med. 2009, 9, 1-8.
14. Ghashm, A.A.; Othman, N.H.; Khattak, M.N.; Ismail, N.M.; Saini, R. Antiproliferative effect of tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines. BMC Complement. Altern. Med. 2010, 10, 49.
15. Mohamed, M.; Sirajudeen, K.N.S.; Swamy, M.; Yaacob, N.S.; Sulaiman, S.A. Studies on the antioxidant properties of tualang honey of Malaysia. Afr. J. Trad. CAM 2010, 7, 59-63.
16. Erejuwa, O.O.; Gurtu, S.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salleh, M.S. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int. J. Vitam. Nutr. Res. 2010, 80, 74-82.
17. Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salzihan, M.S.; Gurtu, S. Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2010, 11, 2056-2066.
18. Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salzihan, M.S.; Gurtu, S. Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in kidney of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2011, 12, 829-843.
19. Trippodo, N.C.; Frolich, E.D. The genetically hypertensive rat as a model for human essential hypertension. Circ. Res. 1981, 48, 309-319.
20. Rakieten, N.; Rakieten, M.L.; Nadkarni, M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 1963, 29, 91-98.
21. Davidoff, A.J.; Pinault, F.M.; Rodgers, R.L. Ventricular relaxation of diabetic spontaneously hypertensive rats. Hypertension 1990, 15, 643-651.
22. Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salzihan, M.S.; Gurtu, S. Universiti Sains Malaysia, Kubang Kerian, Kelantan. Unpublished work, 2010.
23. Roos, M.D.; Wen, X.; Kaihong, S.; Clark, J.A.; Xiaoyong, Y.; Chin, E.; Paterson, A.J.; Kudlow, J.E. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc. Assoc. Am. Phys. 1998, 110, 1-11.
24. Suzuki, H.; Swei, A.; Zweifach, B.W.; Schmid-Schonbein, G.W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: Hydroethidine microfluorography. Hypertension 1995, 25, 1083-1089.
25. Haluzik, M.; Nedvidkova, J. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implication. Physiol. Res. 2000, 49, 37-42.
26. Takasu, N.; Komiya, I.; Asawa, T.; Nagasawa, Y.; Yamada, T. Streptozotocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation. Diabetes 1991, 40, 1141-1145.
27. Pamela, C.C.; Richard, A.H. Biochemistry; J.B. Lippincott Co.: Philadelphia, PA, USA, 1994, pp. 269-280.
28. Stearns, S.B.; Tepperman, H.M.; Tepperman, J. Studies on the utilization and mobilization of lipid in skeletal muscles from streptozotocin-diabetic and control rats. J. Lipid Res. 1979, 20, 654-662.
29. Factor, S.M.; Bhan, R.; Minase, T.; Wolinsky. H.; Sonnenblick, E.H. Hypertensive-diabetic cardiomyopathy in the rat. An experimental model of human disease. Am. J. Pathol. 1981, 102, 219-228.
30. Touyz, R.M.; Schiffrin, E.L. Oxidative stress in arterial hypertension: oxidative stress and hypertension. In Atherosclerosis and Oxidant Stress-A New Perspective; Holtzman, J., Ed.; Springer: New York, NY, USA, 2008; pp. 51-78.
31. Bunag, R.D.; Tomita, T.; Sasaki, S. Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness. Hypertension 1982, 4, 556-565.
32. Sharma, J.N.; Kesavarao, U. Cardiac kallikrein in hypertensive and normotensive rats with and without diabetes. Immunopharmacology 1996, 33, 341-343.
33. To mLinson, K.C.; Gardiner, S.M.; Bennett, T. Blood pressure in streptozotocin-treated Brattleboro and Long Evans rats. Am. J. Physiol. 1990, 258, R852-R859.
34. Rodgers, R.L. Depressor effect of diabetes in the spontaneously hypertensive rat: Associated changes in heart performance. Can. J. Physiol. Pharmacol. 1986, 64, 1177-1184.
35. Kawashima, H.; Igarashi, T.; Nakajima, Y.; Akiyama, Y.; Usuki, K.; Ohtake, S. Chronic hypertension induced by streptozotocin in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 1978, 305, 123-126.
36. Susic, D.; Mandal, A.K.; Jovovic, D.J.; Radujkovic, G.; Kentera, D. Streptozotocin-induced diabetes mellitus lowers blood pressure in spontaneously hypertensive rat. Clin. Exp. Hypertens. A 1990, 12, 1021-1035.
37. Kelly, D.J.; Wilkinson-Berka, J.L.; Allen, T.J.; Cooper, M.E.; Skinner, S.L. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int. 1998, 54, 343-352.
38. Davidoff, A.J.; Rodgers, R.L. Insulin, thyroid hormone, and heart function of diabetic spontaneously hypertensive rat. Hypertension 1990, 15, 633-642.
39. Medeiros, F.J.; Aguila, M.B.; Mandarim-de-Lacerda, C.A. Renal cortex remodeling in streptozotocin-induced diabetic spontaneously hypertensive rats treated with olive oil, palm oil and fish oil from Menhaden. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 357-365.
40. Moreno, J.J.; Carbonell, T.; Sánchez, T.; Miret, S.; Mitjavila, M.T. Olive oil decreases both oxidative stress and the production of arachidonic acid metabolites by the prostaglandin G/H synthase pathway in rat macrophages1. J. Nutr. 2001, 131, 2145-2149.
41. Nyby, M.D.; Abedi, K.; Eslami, P.; Hernandez, G.; Smutko, V.; Berger, M.E.; Tuck, M.L. Dietary fish oil prevents hypertension, oxidative stress and suppression of endothelial nitric oxide synthase expression in fructose-fed rats. Am. J. Hypertens. 2004, 17, 216.
42. Ge, X.; Yu, Q.; Qi, W.; Shi, X.; Zhai, Q. Chronic insulin treatment causes insulin resistance in 3T3-L1 adipocytes through oxidative stress. Free Radic. Res. 2008, 42, 582-591.
43. Tiedge, M.; Lortz, S.; Munday, R.; Lenzen, S. Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by over-expression of antioxidant enzymes in bioengineered insulin-producing RI nm5F cells. Diabetologia 1999, 42, 849-855.
44. Wolff, S.P.; Dean, R.T. Glucose autoxidation and protein modification: The potential role of autoxidative glycosylation in diabetes. Biochem. J. 1987, 245, 243-250.
45. Pigeolet, E.; Corbisier, P.; Houbion, A.; Lambert, D.; Michiels, C.; Raes, M.; Zachary, M.D.; Remacle, J. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 1990, 51, 283-297.
46. Sartori-Valinotti, J.C.; Iliescu, R.; Fortepiani, L.; Yanes, L.; Reckelhoff, J. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease. Clin. Exp. Pharm. Physiol. 2007, 34, 938-945.
47. Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003, 17, 24-38.
48. Newaz, M.A.; Nawal, N.N. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am. J. Hypertens. 1998, 11, 1480-1485.
49. Mantle, D.; Patel, V.B.; Why, H.J.; Ahmed, S.; Rahman, I.; MacNee, W.; Wassif, W.S.; Richardson, P.J.; Preedy, V.R. Effects of lisinopril and a mLodipine on antioxidant status in experimental hypertension. Clin. Chim. Acta 2000, 299, 1-10.
50. Young, I.S. Measurement of total antioxidant capacity. J. Clin. Pathol. 2001, 54, 339-340.
51. Jackson, P.; Loughrey, C.M.; Lightbody, J.H.; McNamee, P.T.; Young, I.S. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin. Chem. 1995, 41, 1135-1138.
52. Nabha, L.; Garbern, J.C.; Buller, C.L.; Charpie, J.R. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin. Exp. Hypertens. 2005, 27, 71-82.
53. Gott, L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 1991, 196, 143-151.
54. Habig, W.H.; Pabst, M.J.; Jakoby, W.B. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130-7139.
55. Goldberg, D.M.; Spooner, R.J. Assay of glutathione reductase. In Methods of Enzymatic Analysis; Bergmeyen, H.V., Ed.; Verlag Chemie: Weinheim, Germany, 1983; pp. 258-265.
56. Koracevic, D.; Koracevic, G.; Djordjevic, V.; Andrejevic, S.; Cosic, V. Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol. 2000, 54, 356-361.
57. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
58. Bradford, M.A. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.